BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3519323)

  • 1. Controlled release of insulin from polymer matrices. In vitro kinetics.
    Brown L; Siemer L; Munoz C; Langer R
    Diabetes; 1986 Jun; 35(6):684-91. PubMed ID: 3519323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of insulin from polymer matrices. Control of diabetes in rats.
    Brown L; Munoz C; Siemer L; Edelman E; Langer R
    Diabetes; 1986 Jun; 35(6):692-7. PubMed ID: 3519324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-demand release by ultrasound from osmotically swollen hydrophobic matrices.
    Aschkenasy C; Kost J
    J Control Release; 2005 Dec; 110(1):58-66. PubMed ID: 16257468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of macromolecules from a degradable polyanhydride matrix.
    Dang W; Saltzman WM
    J Biomater Sci Polym Ed; 1994; 6(3):297-311. PubMed ID: 7527250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of dopamine from a polymeric brain implant: in vitro characterization.
    Freese A; Sabel BA; Saltzman WM; During MJ; Langer R
    Exp Neurol; 1989 Mar; 103(3):234-8. PubMed ID: 2920789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules.
    Sefton MV; Brown LR; Langer RS
    J Pharm Sci; 1984 Dec; 73(12):1859-61. PubMed ID: 6527279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled drug release from implantable matrices based on hydrophobic polymers.
    Di Colo G
    Biomaterials; 1992; 13(12):850-6. PubMed ID: 1457678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer.
    Tallury P; Randall MK; Thaw KL; Preisser JS; Kalachandra S
    Dent Mater; 2007 Aug; 23(8):977-82. PubMed ID: 17049593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical deformation of polymer matrix controlled release devices modulates drug release.
    Edelman ER; Fiorino A; Grodzinsky A; Langer R
    J Biomed Mater Res; 1992 Dec; 26(12):1619-31. PubMed ID: 1484066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled slow release of chemotherapeutic drugs for cancer from matrices prepared by radiation polymerization at low temperatures.
    Kaetsu I; Yoshida M; Yamada A
    J Biomed Mater Res; 1980 May; 14(3):185-97. PubMed ID: 6154055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics.
    Rhine WD; Hsieh DS; Langer R
    J Pharm Sci; 1980 May; 69(3):265-70. PubMed ID: 7189778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.